At @ months , both bone-specific alkaline phosphatase and urinary N-telopeptide were significantly reduced , by @ % ( d = -@ ; @ SE ) and @ % ( d = -@ ; @ SE ) respectively , in the alendronate group ; in the control group , these levels increased ( P < @ ) .